BioLife Solutions, Inc. (BLFS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
BLFS Revenue Growth
Revenue Breakdown (FY 2024)
BLFS's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
BLFS Revenue Analysis (2014–2025)
As of May 8, 2026, BioLife Solutions, Inc. (BLFS) generated trailing twelve-month (TTM) revenue of $99.8 million, reflecting strong growth of +14.9% year-over-year. The most recent quarter (Q1 2026) recorded $27.5 million in revenue, up 46.4% sequentially.
Looking at the longer-term picture, BLFS's 5-year compound annual growth rate (CAGR) stands at +14.9%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $119.2 million in 2021.
Revenue diversification analysis shows BLFS's business is primarily driven by Product (92%), Rental Revenue (7%), and Service (0%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BFLY (+20.2% YoY), AZTA (+1.8% YoY), and CYRX (-7.1% YoY), BLFS has underperformed the peer group in terms of revenue growth. Compare BLFS vs BFLY →
BLFS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| BLFSCurrent | $100M | +14.9% | +14.9% | -12.6% | |
 BFLY | $98M | +20.2% | +16.1% | -88.5% | |
 AZTA | $594M | +1.8% | +8.9% | -1.9% | |
 CYRX | $176M | -7.1% | +17.5% | -20.9% | |
 RGEN | $738M | +17.4% | +15.0% | 8.1% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
BLFS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $96.2M | +17.0% | $62.1M | 64.6% | $-12,130,000 | -12.6% |
| 2024 | $82.3M | +8.4% | $53.7M | 65.3% | $-7,129,000 | -8.7% |
| 2023 | $75.9M | -0.5% | $46.8M | 61.6% | $-23,440,000 | -30.9% |
| 2022 | $76.2M | -36.0% | $46.9M | 61.5% | $-5,923,000 | -7.8% |
| 2021 | $119.2M | +147.8% | $28.8M | 24.2% | $-35,160,000 | -29.5% |
| 2020 | $48.1M | +75.7% | $27.4M | 57.1% | $-3,332,000 | -6.9% |
| 2019 | $27.4M | +38.6% | $18.5M | 67.6% | $-781,000 | -2.9% |
| 2018 | $19.7M | +79.1% | $13.5M | 68.5% | $3.7M | 18.5% |
| 2017 | $11.0M | +34.0% | $6.7M | 61.2% | $-1,056,000 | -9.6% |
| 2016 | $8.2M | +27.6% | $4.8M | 58.1% | $-4,851,000 | -59.0% |
See BLFS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BLFS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BLFS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBLFS — Frequently Asked Questions
Quick answers to the most common questions about buying BLFS stock.
Is BLFS's revenue growth accelerating or slowing?
BLFS maintains +14.9% revenue growth, in line with its 5-year CAGR of +14.9%. TTM revenue stands at $100M. Growth rate remains consistent with historical average.
What is BLFS's long-term revenue growth rate?
BioLife Solutions, Inc.'s 5-year revenue CAGR of +14.9% reflects the sustained expansion pattern. Current YoY growth of +14.9% is near this long-term average.
How is BLFS's revenue distributed by segment?
BLFS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.